DIAGNOSTIC HEALTH SERVICES INC /DE/
15-12G, 2000-11-17
MEDICAL LABORATORIES
Previous: CORPORATE INCOME FD INSURED SERIES 29 DEFINED ASSET FDS, 497, 2000-11-17
Next: CMC SECURITIES CORP II, 8-K, 2000-11-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number    0-21758   

Diagnostic Health Services, Inc.
______________________________________________________________________________

(Exact name of registrant as specified in its charter)

2777 Stemmons Freeway, Suite 1525
Dallas, Texas 75207
(214) 634-0403
______________________________________________________________________________

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common Stock, par value $0.001 per share
______________________________________________________________________________

(Title of each class of securities covered by this Form)

None
______________________________________________________________________________

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

          Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)(i)
Rule 12g-4(a)(1)(ii)
Rule 12g-4(a)(2)(i)
Rule 12g-4(a)(2)(ii)

ý
o
o
o

 

Rule 12h-3(b)(1)(i)
Rule 12h-3(b)(2)(i)
Rule 12h-3(b)(2)(ii)
Rule 15d-6

ý
o
o
o

 

          Approximate number of holders of record as of the certification or notice date:     0     

          Pursuant to the requirements of the Securities Exchange Act of 1934, Diagnostic Health Services, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

Date: November ___, 2000

By: _________________________________________
       Name: Christopher Turner
       Title: Chief Executive Officer



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission